Valuation: Psychemedics Corporation

Market Cap 9.79M 8.77M 8.07M 7.31M 13.66M 930M 13.92M 96.19M 38.61M 489M 36.75M 35.96M 1.54B P/E 2023
-4.09x
P/E 2024 -7x
Enterprise Value 9.54M 8.54M 7.86M 7.12M 13.31M 906M 13.56M 93.72M 37.62M 477M 35.8M 35.04M 1.5B EV / Sales 2023
0.79x
EV / Sales 2024 0.68x
Free-Float
44.15%
Yield 2023
2.36%
Yield 2024 -
1 week-3.61%
Current month-3.61%
1 month-3.61%
3 months-3.61%
6 months+9.09%
Current year+50.00%
Current year 1.33
Extreme 1.33
2.7
1 year 1.33
Extreme 1.33
2.7
3 years 1.11
Extreme 1.11
3.93
5 years 1.11
Extreme 1.11
8.9
10 years 1.11
Extreme 1.11
27.99
Manager TitleAgeSince
Chief Executive Officer 59 17/08/2023
Director of Finance/CFO 36 27/11/2023
Corporate Officer/Principal 40 21/09/2023
Director TitleAgeSince
Director/Board Member 64 16/03/2021
Director/Board Member 58 04/04/2022
Director/Board Member 64 12/08/2022
Date Insider Type Main position Quantity % Market Cap. Importance
13/12/24
Powell Anderson Capital Partners
BuyCompany 159,700 2.7093%
10/12/24
Powell Anderson Capital Partners
BuyCompany 86,991 1.4758%
10/12/24 Sell

Director

320,708 5.4408%
Change 5-day change 1-year change 3-year change Capi.($)
-.--%-3.61%+16.50%-2.04% 15.26M
-0.09%-3.44%+15.48%+30.78% 115B
-1.02%+0.89%+2.94%+109.25% 98.85B
-4.98%+2.56%+108.26%+949.66% 59.72B
+1.44%+1.95%-6.04%+93.89% 30.06B
-1.84%+9.86%+42.30%+80.94% 29.34B
-0.43%+4.11%+43.12%+93.56% 27.71B
+0.99%+1.79%+32.33%+408.85% 21.75B
-1.58%+2.35%-18.66%-15.18% 20.66B
-.--%-0.63%-4.85%+30.83% 17.09B
Average -0.75%+2.26%+23.14%+178.05% 42.06B
Weighted average by Cap. -1.05%+1.07%+26.23%+209.12%

Financials

2023 2024
Net sales 22.1M 19.79M 18.2M 16.49M 30.83M 2.1B 31.41M 217M 87.15M 1.1B 82.93M 81.17M 3.48B 19.68M 17.63M 16.22M 14.69M 27.47M 1.87B 27.98M 193M 77.63M 983M 73.88M 72.3M 3.1B
Net income -4.15M -3.72M -3.42M -3.1M -5.8M -394M -5.9M -40.81M -16.38M -207M -15.59M -15.26M -654M -1.86M -1.67M -1.53M -1.39M -2.6M -177M -2.65M -18.28M -7.34M -92.95M -6.98M -6.84M -293M
Net Debt 334K 299K 275K 249K 466K 31.71M 475K 3.28M 1.32M 16.68M 1.25M 1.23M 52.61M -251K -225K -207K -187K -350K -23.83M -357K -2.47M -990K -12.54M -942K -922K -39.54M
Projected Income Statement - Annual - Psychemedics Corporation
Logo Psychemedics Corporation
Psychemedics Corporation is a hair drug testing company. The Company provides testing services for the detection of drugs of abuse through the analysis of hair samples. Its testing methods utilize a patented technology that digests the hair and releases drugs trapped in the hair without destroying the drugs. The Company customizes its enzyme immunoassay (EIA) procedures to drug test hair samples. It provides screening and confirmation by mass spectrometry using industry-accepted practices for cocaine, marijuana, phenylcyclohexyl piperidine (PCP), amphetamines (including ecstasy, eve, and Adderall), opiates (including heroin, hydrocodone, hydromorphone, oxycodone and codeine), synthetic cannabinoids (including K2, Spice, Blaze), benzodiazepines (Xanax, Valium, and Ativan), nicotine, Fentanyl, and alcohol. The Company markets its corporate drug testing services through its own sales force, distributors, and partners. It markets its home drug testing service, PDT-90, through the Internet.
Employees
101
  1. Stock Market
  2. Stocks
  3. PMDI Stock